Mov Disord Vol 34, Suppl 2 Archives - Page 200 of 217 - MDS Abstracts

2019 International Congress
Genetic markers revealed in dysregulated pathways in ischemic stroke may lead to Parkinson’s disease
H. Singh, V. Swarup, A. Srivastava (Marseille, France)
Objective: To assess differential expression and gene set enrichment analysis to identify biological pathways associated with stroke and Parkinson’s disease (PD). Further, putative drug targets…
2019 International Congress
SLC6A4 repeat and single-nucleotide polymorphisms are associated with depression and rest tremor in Parkinson’s disease
X. Zhang, M. Zou, R. Liu, J. Wang, Q. Fan (Wenzhou, China)
Objective: The objective of the current study was to determine whether the SLC6A4 polymorphisms were associated with key motor and non-motor symptoms of PD. Background:…
2019 International Congress
Acquired (non-Wilsonian) hepatocerebral degeneration: case report
E. Gracheva, I. Miliukhina, A. Sokolov, YU. Seliverstov (St.petersburg, Russian Federation)
Objective: To present a case of the patient with acquired (non-Wilsonian) hepatocerebral degeneration (AHD). Background: AHD is a clinical syndrome which includes movement and cognitive…
2019 International Congress
Hyperkinetic Movement Disorders in Congenital Disorders of Glycosylation
G. Mostile, R. Barone, A. Nicoletti, R. Rizzo, D. Martinelli, L. Sturiale, A. Fiumara, J. Jankovic, M. Zappia (Catania, Italy)
Objective: The aim of the current study was to investigate hyperkinetic movement disorders in patients affected by Congenital Disorders of Glycosylation (CDG) and to characterize…
2019 International Congress
Super-urgent liver transplantation for a 62 year old with Wilson’s disease presenting with acute liver failure
S. Shribman, A. Shenoy, W. Griffiths, A. Gimson, T. Warner (London, United Kingdom)
Objective: We describe an intriguing case of Wilson’s disease presenting with acute (fulminant) liver failure. Background: Wilson’s disease usually presents between the age of 5…
2019 International Congress
Neuritic pathology in Parkinson’s Disease results from loss of anti-oxidant response activity
S. Ryan, M. Stykel, C. Coackley, T. Ryan (Guelph, ON, Canada)
Objective: To determine the link between α-syn accumulation and neuritic pathology in Parkinson’s Disease (PD). Background: Neurological dysfunction in PD is highly associated with pathological…
2019 International Congress
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD)
M. Figorilli, P. Pisanu, M. Mascia, M. Meloni, R. Lecca, G. Gioi, P. Congiu, L. Tamburrino, G. Defazio, ML. Fantini, M. Puligheddu (Monserrato, Italy)
Objective: to assess the correlations between the severity of RSWA and cognitive functions in patients with RBD, both isolated (iRBD) and associated to Parkinson’s Disease…
2019 International Congress
Sleep disordered breathing and REM sleep behavior disorder in military Veterans with Parkinson’s disease
A. Sarwar, S. Moore (Houston, TX, USA)
Objective: To study the association of sleep disordered breathing with REM sleep behavior disorder in US military Veterans with Parkinson’s disease. Background: Both REM sleep…
2019 International Congress
Patient insights into the burden of OFF-episodes in Parkinson’s disease: Qualitative Interviews
C. Ervin, J. Sutphin, A. Thach, A. Lee, C. Mansfield, J. Coulter (Research Triangle Park, NC, USA)
Objective: Identify symptoms and impacts associated with OFF-episodes (OEs). Background: OFF-episodes are commonly experienced in patients with Parkinson’s disease (PD). Qualitative research into patients’ experience…
2019 International Congress
Stigma in Egyptian patients with Parkinson’s disease
M. Salim, A. Helmy, A. Shalash, E. Abdel Dayem (Cairo, Egypt)
Objective: In this study we aimed to investigate stigma in Egyptian Parkinson’s disease patients using a culturally adapted Arabic version of the 39-item Parkinson's disease…